PepGen Inc. posted a net loss of $18.03 million for the third quarter ended September 30, 2025, a 16% improvement from the $21.4 million loss reported for the same period last year. The loss per share of $0.52 beat the consensus estimate of $0.56, largely because operating expenses fell to $18.65 million, driven by a $4.3 million reduction in research and development spending compared with $17.7 million in Q3 2024. The company’s cash, cash equivalents and market‑able securities stood at $163.7 million, giving it a runway that extends into the second half of 2027.
Continue reading for full analysis...